USP8 pseudogene 2 (USP8P2)

USP8 pseudogene 2 (USP8P2) is classified as a pseudogene of the USP8 gene. Pseudogenes are genetic sequences that resemble known genes but are generally non-functional due to accumulated mutations or lack of regulatory elements. According to available data, USP8P2 does not encode an active protein or have a known biological function and is not considered a therapeutic target. There is no evidence of disease association, pharmacological modulation, or clinical biomarker utility for USP8P2. Pseudogenes such as USP8P2 are sometimes misidentified as active gene targets, but current scientific consensus does not support a role as a druggable or disease-relevant molecule[1][4]. Key fact: USP8P2 is a pseudogene related to the active gene Ubiquitin specific peptidase 8 (USP8), which is involved in processes such as endosomal sorting and known to be a therapeutic target in contexts like Cushing’s disease and cancer[1][2][3]. However, pseudogenes themselves, including USP8P2, are generally not considered therapeutic targets nor do they have the functions, disease relevance, or drug interactions associated with the protein-coding parent gene. Notes on potential confusion: If your query is meant for USP8 (Ubiquitin specific peptidase 8), rather than USP8P2, please clarify, as the parent gene/protein is enzymatically active, involved in important cellular pathways, and has clinical significance in diseases such as Cushing’s disease[1][2][3][4][5]. However, as written, USP8P2 refers to a non-coding pseudogene, which is not a valid therapeutic target.

Other names

USP8P2